BR0207447A - Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina - Google Patents

Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina

Info

Publication number
BR0207447A
BR0207447A BR0207447-8A BR0207447A BR0207447A BR 0207447 A BR0207447 A BR 0207447A BR 0207447 A BR0207447 A BR 0207447A BR 0207447 A BR0207447 A BR 0207447A
Authority
BR
Brazil
Prior art keywords
useful
streptococcus pyogenes
vaccine components
dna fragments
corresponding polypeptides
Prior art date
Application number
BR0207447-8A
Other languages
English (en)
Other versions
BRPI0207447B1 (pt
Inventor
Denis Martin
Stephane Rioux
Bernard R Brodeur
Josee Hamel
Patrick Rheault
Original Assignee
Shire Biochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc
Publication of BR0207447A publication Critical patent/BR0207447A/pt
Publication of BRPI0207447B1 publication Critical patent/BRPI0207447B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"POLIPEPTìDEOS E FRAGMENTOS DE DNA CORRESPONDENTES DE STREPTOCOCCUS PYOGENES úTEIS COMO COMPONENTES DE VACINA". A presente invenção está relacionada a antígenos, mas particularmente antígenos de patógeno bacteriano de Streptococcus pyogenes (também chamado Streptococcus de grupo A (GAS)) que são úteis como componentes de vacina para profilaxia, terapia e/ou diagnóstico.
BRPI0207447A 2001-02-21 2002-02-21 polipeptídeo recombinante isolado, seu uso e processo de produção, vetor de expressão, célula hospedeira microbiana transgênica, composição farmacêutica, uso da dita composição, métodos de detecção e kit BRPI0207447B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26984001P 2001-02-21 2001-02-21
PCT/CA2002/000207 WO2002066650A2 (en) 2001-02-21 2002-02-21 Streptococcus pyogenes polypeptides and corresponding dna fragments

Publications (2)

Publication Number Publication Date
BR0207447A true BR0207447A (pt) 2004-06-29
BRPI0207447B1 BRPI0207447B1 (pt) 2015-09-22

Family

ID=23028867

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0207447A BRPI0207447B1 (pt) 2001-02-21 2002-02-21 polipeptídeo recombinante isolado, seu uso e processo de produção, vetor de expressão, célula hospedeira microbiana transgênica, composição farmacêutica, uso da dita composição, métodos de detecção e kit

Country Status (10)

Country Link
US (2) US7482012B2 (pt)
EP (1) EP1362106B1 (pt)
JP (1) JP4281861B2 (pt)
AT (1) ATE456659T1 (pt)
AU (1) AU2002234455C1 (pt)
BR (1) BRPI0207447B1 (pt)
CA (1) CA2438921C (pt)
DE (1) DE60235223D1 (pt)
ES (1) ES2338637T3 (pt)
WO (1) WO2002066650A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
AU2008207670B2 (en) * 2001-04-13 2011-06-16 Wyeth Surface proteins of streptococcus pyogenes
WO2002088178A2 (en) * 2001-05-02 2002-11-07 Shire Biochem Inc. Antigens of group b streptococcus and corresponding dna fragments
ATE361097T1 (de) * 2002-01-15 2007-05-15 Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh Orale vakzinierung mit dem tumor-antigen-mimotop gln-met-trp-ala-pro-gln-trp-gly-pro-asp
CN1756843B (zh) * 2003-03-04 2012-03-21 英特塞尔股份公司 化脓链球菌抗原
EP2311988A1 (en) 2003-04-15 2011-04-20 Intercell AG S. pneumoniae antigens
ES2432013T3 (es) * 2003-08-15 2013-11-29 Id Biomedical Corporation Of Quebec Composiciones farmacéuticas para usar en el tratamiento de la infección por Streptococcus Pyogenes
WO2007119779A1 (ja) 2006-04-14 2007-10-25 Nec Corporation 個体識別方法および装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040144A (en) * 1997-07-25 2000-03-21 Mount Sinai School Of Medicine Procedure for preparing gene expression libraries enriched for secretory protein genes
US6033673A (en) * 1998-03-18 2000-03-07 The Administrators Of Tulane Educational Fund Double mutant enterotoxin for use as an adjuvant
GB9807890D0 (en) * 1998-04-09 1998-06-10 Actinova Ltd Peptides
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
MXPA03003690A (es) 2000-10-27 2004-05-05 Chiron Spa Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
FR2824074A1 (fr) 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
WO2002088178A2 (en) 2001-05-02 2002-11-07 Shire Biochem Inc. Antigens of group b streptococcus and corresponding dna fragments
GB0210128D0 (en) 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
CN1756843B (zh) 2003-03-04 2012-03-21 英特塞尔股份公司 化脓链球菌抗原

Also Published As

Publication number Publication date
US20030049271A1 (en) 2003-03-13
BRPI0207447B1 (pt) 2015-09-22
EP1362106A2 (en) 2003-11-19
JP2004531235A (ja) 2004-10-14
AU2002234455B2 (en) 2008-01-17
US7482012B2 (en) 2009-01-27
CA2438921C (en) 2012-04-10
ES2338637T3 (es) 2010-05-11
JP4281861B2 (ja) 2009-06-17
DE60235223D1 (de) 2010-03-18
US7883706B2 (en) 2011-02-08
WO2002066650A2 (en) 2002-08-29
EP1362106B1 (en) 2010-01-27
CA2438921A1 (en) 2002-08-29
ATE456659T1 (de) 2010-02-15
US20090186820A1 (en) 2009-07-23
WO2002066650A3 (en) 2002-10-31
AU2002234455C1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1109683T1 (el) Αντιγονα του streptococcus pyogenes
DE69938302D1 (de) Neisseria meningitidis antigene und zusammenstellungen
DE60027890D1 (de) Streptococcus pneumoniae proteine und impfstoffe
WO2003054007A3 (en) Streptococcus antigens
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
NZ524888A (en) Nucleic acids and proteins from streptococcus groups A & B
EP2336174B8 (en) Human monoclonal antibodies against Hendra and Nipah viruses
TR200102497T2 (tr) Yeni streptococcus antijenleri
FR21C1005I2 (fr) Antigenes de streptococcus pyogenes et fragments d'adn correspondants
DK1292328T3 (da) Kimære humant papillomvirus- (HPV) - molekyler og deres anvendelse
ATE542829T1 (de) Impfstoff
DE60036698D1 (de) Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
WO2008108830A8 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
BR0112497A (pt) Antìgenos de streptococcus pyogenes
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
WO2021158755A3 (en) Leptospiral proteins and uses thereof
WO2005032491A3 (en) Methods and compositions for mycoplasma pneumoniae exotoxins
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
BR0308180A (pt) protéinas de superfìcie de leptospira
WO2002077648A3 (en) Pathogenic and commensal vaccine antigens

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: SHIRE BIOCHEM INC. (CA)

Free format text: SEDE ALTERADA CONFORME SOLICITACAO NA PETICAO NO 0/20050112588/RJ DE 11/10/2005.

B25A Requested transfer of rights approved

Owner name: ID BIOMEDICAL CORPORATION (CA)

Free format text: TRANSFERIDO DE: SHIRE BIOCHEM INC.

B25G Requested change of headquarter approved

Owner name: ID BIOMEDICAL CORPORATION (CA)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070101374/RJ DE 24/07/2007.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: ID BIOMEDICAL CORPORATION OF QUEBEC (CA)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/09/2015, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: REFERENTE AO DESPACHO 21.6 PUBLICADO NA RPI 2554 DE 2019-12-17